PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
10-Oct-2024 PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting PureTech Health plc
10-Oct-2024 Purespring Therapeutics raises £80 million in a Series B financing Syncona Ltd
10-Oct-2024 Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally Advanced or Metastatic Non-Small Cell Lung Cancer Driven by EGFR Exon 19 or 21 and Co-occurring C797S Mutations Pierre Fabre Laboratories
10-Oct-2024 ACG Accelerates European Growth with Major Expansion in Croatia ACG
10-Oct-2024 Mestag Therapeutics Announces License and Research Collaboration with MSD to Identify Novel Targets for Inflammatory Diseases Mestag Therapeutics
10-Oct-2024 Elafibranor approved as first medicine to treat adults with a rare liver disease known as primary biliary cholangitis MHRA
10-Oct-2024 Veranova Expands Advisory Board with Appointment of Dr. Rajni Aneja and Dr. Bradley L. Pentelute Veranova
09-Oct-2024 The Future of Clinical Research Education: Trends and Courses Fusion Technology Solutions
09-Oct-2024 Preliminary Data of BellaSeno’s Clinical Trial on Scaffold-Guided Breast Regeneration Presented at the 93rd Annual Plastic Surgery Meeting in San Diego, CA BellaSeno GmbH
08-Oct-2024 Adcendo Announces US FDA Clearance of IND Application for Phase I/II First-in-Human ADCElerate-01 Trial of ADCE-D01 (uPARAP Receptor Targeting ADC) Trial in Patients With Metastatic and/or Unresectable Soft Tissue Sarcoma (STS) Adcendo
08-Oct-2024 EVERSANA Expands Global Commercialisation Operations With Berlin, Germany Office EVERSANA
08-Oct-2024 MONCYTE Health Raises EUR 1 Million Seed Capital to Advance Personalized Treatment for High Cholesterol MONCYTE Health
07-Oct-2024 ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries ViiV Healthcare
07-Oct-2024 EVERSANA Expands Global Commercialisation Operations With Berlin, Germany Office EVERSANA
07-Oct-2024 Myricx Bio Announces Appointment of Paolo Paoletti MD as an Independent Non Executive Director Myricx Bio
07-Oct-2024 RoukenBio completes phase 2 discovery centre expansion and unveils new brand identity RoukenBio
07-Oct-2024 Microbiotica Announces First Patient Dosed in its International Phase 1b Trial, MELODY-1 of MB097 Precision Microbiome Co-Therapy in Advanced Melanoma Microbiotica
07-Oct-2024 PulseSight Therapeutics to Present Data on PST-611 at EVER Congress 2024 PulseSight Therapeutics SAS
07-Oct-2024 Avillion announces positive high-level results from Phase III BATURA trial with AstraZeneca’s inhaled anti-inflammatory medication Airsupra in asthma patients Avillion and AstraZeneca
07-Oct-2024 ViroCell Biologics to host panel event at 2024 Cell & Gene Meeting on the Mesa ViroCell Biologics